Computational Prediction of Viral Glycoprotein Dynamics: From Sequence to 3D Structure and Immune Evasion

Introduction

Viral glycoproteins are the primary molecular determinants of host cell tropism, membrane fusion, and immune recognition. These surface-exposed proteins mediate the initial attachment of virions to host cell receptors and catalyze the fusion of viral and cellular membranes, a process essential for productive infection [1]. In veterinary virology, glycoproteins from pathogens such as avian influenza virus hemagglutinin, rabies virus G protein, and infectious bronchitis virus spike protein represent critical targets for vaccine design and diagnostic development [2, 3]. The conformational plasticity of these glycoproteins, which often transition between metastable prefusion and stable postfusion states, poses a significant challenge for both structural characterization and immunological intervention [1, 4].

Computational methods have emerged as indispensable tools for predicting the three-dimensional (3D) structures and dynamic behaviors of viral glycoproteins. These methods span from template-based homology modeling and ab initio folding to advanced deep learning architectures such as AlphaFold2 [1]. Molecular dynamics (MD) simulations further enable the exploration of conformational ensembles, providing atomic-level insights into receptor binding, antibody neutralization, and immune evasion mechanisms [5, 6, 7]. This review provides a comprehensive examination of the computational pipeline from primary sequence to dynamic 3D structure, with a focus on applications in veterinary medicine and comparative virology.

Sequence-Based Prediction of Glycoprotein Structure

Primary Sequence Analysis and Feature Extraction

The computational prediction of glycoprotein structure begins with the analysis of the primary amino acid sequence. Conserved sequence motifs, such as the fusion peptide in class I fusion proteins, can be identified through multiple sequence alignment and hidden Markov model-based profiling [1]. The identification of glycosylation sequons (N-X-S/T) is a critical early step, as the glycan shield profoundly influences protein folding, receptor accessibility, and antibody evasion [4]. Sequence-based predictors of glycosylation sites are routinely integrated into structural modeling pipelines to inform the placement of glycan moieties.

Homology Modeling and Threading

For glycoproteins with known structural homologs, comparative modeling remains a reliable approach. The Protein Data Bank (PDB) serves as the primary repository for experimentally determined structures, including those of viral glycoproteins in various conformational states. Threading algorithms, which align a query sequence against a library of known folds, can identify structural templates even in the absence of significant sequence identity. This approach has been applied to the structural prediction of glycoproteins from emerging viruses such as Bourbon virus and Chandipura virus [8, 9].

Deep Learning-Based Structure Prediction

The advent of AlphaFold2 and related deep learning architectures has revolutionized protein structure prediction. These methods leverage co-evolutionary information derived from multiple sequence alignments and attention-based neural networks to predict inter-residue distances and torsion angles [1]. A landmark study demonstrated that AlphaFold2 can accurately predict both prefusion and postfusion conformations of class I fusion proteins, including those from paramyxoviruses and coronaviruses [1]. This capability is particularly valuable for veterinary pathogens for which experimentally determined structures are unavailable. The application of AlphaFold2 to viral glycoproteins is further discussed in the article Structural Prediction of Viral Envelope Glycoproteins Using AlphaFold2: Implications for Host Receptor Binding and Vaccine Design.

Molecular Dynamics Simulations of Glycoprotein Conformational Ensembles

Force Fields and System Preparation

Molecular dynamics simulations rely on classical force fields, such as CHARMM and AMBER, to model the physical interactions between atoms in a glycoprotein system [5]. The preparation of a simulation system involves solvating the protein in a water box, adding counterions to neutralize the system, and energy minimization to remove steric clashes. For membrane-embedded glycoproteins, the construction of a lipid bilayer environment is essential for capturing the native conformational dynamics of transmembrane domains and fusion machinery [10].

Simulation of Conformational Transitions

Viral glycoproteins undergo large-scale conformational rearrangements during the fusion process. For class I fusion proteins, the transition from the prefusion to the postfusion state involves the refolding of the heptad repeat regions into a six-helix bundle [1]. MD simulations can capture these transitions when enhanced sampling techniques, such as replica exchange molecular dynamics or metadynamics, are employed [5]. These simulations reveal the energetic barriers and intermediate states along the fusion pathway, providing targets for small-molecule inhibitors and neutralizing antibodies [11, 12].

Analysis of Receptor Binding Dynamics

The binding of viral glycoproteins to host cell receptors is a critical determinant of host range and tissue tropism. MD simulations, combined with binding free energy calculations using methods such as molecular mechanics generalized Born surface area (MM-GBSA), can quantify the impact of specific mutations on receptor affinity [5, 13]. For example, integrative MD analysis of the angiotensin-converting enzyme 2 (ACE2) receptor binding domain (RBD) interaction has elucidated mutation-driven adaptation mechanisms in emerging coronaviruses [5]. These computational approaches are detailed in the article Computational Prediction of Spike Protein Mutations and ACE2 Binding Dynamics in Emerging Coronaviruses.

Machine Learning for Immune Evasion Prediction

Epitope Prediction and Antibody Escape

The identification of B-cell and T-cell epitopes is a cornerstone of computational vaccinology. Machine learning classifiers, trained on experimentally validated epitope data, can predict linear and conformational epitopes from glycoprotein sequences and structures [2, 14]. These predictions inform the design of multi-epitope vaccines that elicit broad neutralizing antibody responses [15, 16, 17]. Furthermore, the structural mapping of epitopes onto glycoprotein surfaces enables the prediction of antibody escape mutations. Dynamic mutational profiling, which combines MD simulations with alanine scanning, has identified hotspots of immune escape in the SARS-CoV-2 spike protein [6, 7, 18]. Similar approaches are applicable to veterinary coronaviruses such as infectious bronchitis virus [3].

Glycan Shield Modeling

The glycan shield of viral glycoproteins presents a steric and electrostatic barrier to antibody recognition. Computational modeling of glycan conformations, using tools such as Glycan Reader and GLYCAM, allows for the prediction of glycan-mediated epitope masking [4]. MD simulations of fully glycosylated glycoproteins reveal the dynamic nature of the glycan shield, which can shift in response to mutations or antibody pressure. The structural bioinformatics of glycan shield evasion is explored in the article Structural Bioinformatics of Viral Glycoprotein Glycan Shield Evasion.

Deep Learning for Variant Effect Prediction

Deep learning models, including graph neural networks and transformers, have been trained to predict the phenotypic consequences of glycoprotein mutations. These models integrate sequence, structural, and evolutionary features to estimate changes in protein stability, receptor binding affinity, and antibody escape potential [4, 13]. The application of these models to viral glycoproteins enables the prospective surveillance of emerging variants and the identification of mutations that confer immune evasion [7, 18].

Computational Design of Vaccines and Therapeutics

Multi-Epitope Vaccine Design

Reverse vaccinology and immunoinformatics approaches have been extensively applied to the design of multi-epitope vaccines against veterinary viruses. These pipelines involve the prediction of cytotoxic T lymphocyte (CTL), helper T lymphocyte (HTL), and B-cell epitopes from glycoprotein sequences, followed by the assembly of epitopes into a single vaccine construct using appropriate linkers and adjuvants [2, 14, 15, 16, 3, 8, 19, 20, 17, 21]. The 3D structure of the vaccine construct is then predicted and validated through MD simulations to ensure proper folding and stability [15, 16, 21]. Examples include vaccines against avian influenza virus [2], infectious bronchitis virus [3], rabies virus [17], and Marburg virus [21].

Structure-Based Drug Design

The atomic-level understanding of glycoprotein dynamics facilitates the rational design of small-molecule inhibitors and peptide-based entry blockers. Virtual screening campaigns, targeting conserved binding pockets such as the fusion peptide groove or the receptor binding site, have identified candidate inhibitors for respiratory syncytial virus [11], human metapneumovirus [12], Ebola virus [22], and SARS-CoV-2 [23, 24, 25]. MD simulations are used to refine docking poses, calculate binding free energies, and assess the conformational stability of inhibitor-bound complexes [11, 12, 22, 23, 24, 26, 10, 27, 28]. These computational strategies are reviewed in the article Computational Strategies in Structure Based Drug Design.

Antibody Engineering and Optimization

Computational methods are increasingly used to engineer antibodies with enhanced affinity and breadth of neutralization. Deep learning models, combined with MD simulations, can predict the binding affinity of antibody variants and guide the optimization of complementarity-determining regions [29]. Structure-guided engineering has been applied to antibodies targeting Zika virus envelope protein [29] and SARS-CoV-2 spike protein [6, 7, 18]. The design of antibody-like binders and peptide inhibitors is further discussed in the article Computational Design of Viral Glycoprotein Binders for Neutralization.

Integrated Computational Workflow

The following Mermaid diagram illustrates a typical integrated workflow for the computational prediction of viral glycoprotein dynamics, from sequence acquisition to immune evasion analysis.

flowchart TD
    A[Viral Glycoprotein Sequence], > B[Sequence Analysis & Feature Extraction]
    B, > C[Glycosylation Site Prediction]
    B, > D[Conserved Motif Identification]
    D, > E[Template Selection & Homology Modeling]
    C, > E
    E, > F[AlphaFold2 Structure Prediction]
    F, > G[3D Structure Validation & Refinement]
    G, > H[Molecular Dynamics Simulations]
    H, > I[Conformational Ensemble Analysis]
    I, > J[Receptor Binding Dynamics]
    I, > K[Fusion Mechanism Elucidation]
    J, > L[Binding Free Energy Calculations]
    K, > L
    L, > M[Mutation Scanning & Variant Effect Prediction]
    M, > N[Immune Evasion Hotspot Identification]
    N, > O[Epitope Prediction & Vaccine Design]
    N, > P[Antibody Escape Prediction]
    O, > Q[Multi-Epitope Vaccine Construct]
    P, > R[Antibody Engineering & Optimization]
    Q, > S[In Silico Vaccine Validation]
    R, > S
    S, > T[Experimental Validation]

Key Databases and Resources

The computational prediction of glycoprotein dynamics relies on several publicly available databases and tools. The PDB provides experimentally determined structures of viral glycoproteins, which serve as templates for homology modeling and validation of predicted structures. UniProt offers annotated sequence data, including glycosylation sites and domain architectures. Specialized databases, such as the Influenza Research Database and the Virus Pathogen Resource, provide curated glycoprotein sequences and metadata for veterinary pathogens. The integration of these resources into computational pipelines is essential for accurate and reproducible predictions.

Challenges and Future Directions

Despite significant advances, several challenges remain in the computational prediction of viral glycoprotein dynamics. The accurate modeling of glycans and their conformational heterogeneity is an ongoing area of research [4]. The prediction of conformational transitions, particularly for large glycoprotein complexes, requires enhanced sampling methods and increased computational resources [1]. Furthermore, the integration of cryo-electron microscopy (cryo-EM) data with computational models offers a promising avenue for improving the accuracy of structure predictions [4]. The development of machine learning models that can generalize across diverse viral families and host species is a key priority for veterinary virology.

Conclusion

Computational methods have transformed the study of viral glycoprotein dynamics, enabling the prediction of 3D structures, conformational ensembles, and immune evasion mechanisms from primary sequence data. These approaches have direct applications in veterinary medicine, including the design of multi-epitope vaccines, the discovery of antiviral compounds, and the surveillance of emerging viral variants. The continued integration of deep learning, molecular dynamics, and experimental structural biology will further enhance our ability to predict and counteract the adaptive evolution of viral glycoproteins.

References

[1] Gülesen S, Most V, Schoeder CT et al. Prediction of pre- and postfusion conformations of class I fusion proteins with AlphaFold2. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/42302011/

[2] Khursheed S, Ahmed MZ, Khursheed S et al. Bioinformatics-guided vaccine targeting the hemagglutinin protein of avian influenza virus. Mol Genet Genomics. 2026. https://pubmed.ncbi.nlm.nih.gov/41686297/

[3] Dey S, Gates H, Salehi R et al. AstraMEV (AI-Guided Structural Assembly of Multi-Epitope Vaccines) Against Infectious Bronchitis Virus. J Chem Inf Model. 2025. https://pubmed.ncbi.nlm.nih.gov/41131667/

[4] Herzig JC, Magwira ML, Lovell SC. Structural Constraints Acting on the SARS-CoV-2 Spike Protein Reveal Limited Space for Viral Adaptation. Genome Biol Evol. 2026. https://pubmed.ncbi.nlm.nih.gov/41876430/

[5] Truong Hoai L, Ilham B, Sompornpisut T et al. Mutation-driven adaptation of ACE2-RBD binding revealed by integrative molecular dynamics analysis. J Mol Graph Model. 2026. https://pubmed.ncbi.nlm.nih.gov/41839468/

[6] Alshahrani M, Parikh V, Foley B et al. Dissecting binding and immune evasion mechanisms for ultrapotent Class I and Class 4/1 neutralizing antibodies of SARS-CoV-2 spike protein using a multi-pronged computational approach: neutral frustration architecture of binding interfaces and immune escape hotspots drives adaptive evolution. Phys Chem Chem Phys. 2026. https://pubmed.ncbi.nlm.nih.gov/41623222/

[7] Alshahrani M, Parikh V, Foley B et al. Multiscale Modeling and Dynamic Mutational Profiling of Binding Energetics and Immune Escape for Class I Antibodies with SARS-CoV-2 Spike Protein: Dissecting Mechanisms of High Resistance to Viral Escape Against Emerging Variants. Viruses. 2025. https://pubmed.ncbi.nlm.nih.gov/40872744/

[8] Naderian R, Ahmad S, Rahmanian M et al. Rational design of multi-epitope vaccine for Chandipura virus using an immunoinformatics approach. PLoS One. 2025. https://pubmed.ncbi.nlm.nih.gov/41129557/

[9] Hussain I, Haq IU, Rahiyab M et al. Structure-guided drug repurposing and dynamics simulation reveal anti-viral candidates for Bourbon virus. In Silico Pharmacol. 2025. https://pubmed.ncbi.nlm.nih.gov/41113167/

[10] Dubey A, Kumar M, Tufail A. Inhibiting viral entry of bat-derived coronavirus HKU5-CoV-2: Targeting spike protein S1 subunit with FDA-approved antivirals-A structural dynamics and energetics study. Bioorg Chem. 2025. https://pubmed.ncbi.nlm.nih.gov/40865231/

[11] Zhou X, Du H, Wang C et al. Identification of a Potential Dual-Target Candidate Against RSV F Protein and 15-LOX from TCMSP: Integrating Virtual Screening, Molecular Dynamics, and Experimental Evaluation. Int J Mol Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42074092/

[12] Dubey A, Kumar M, Tufail A. Suppressing viral assembly in human metapneumovirus by targeting fusion protein with natural compounds: a structural dynamics and energetics study. J Mol Model. 2026. https://pubmed.ncbi.nlm.nih.gov/42043606/

[13] Nguyen DN, Nguyen QT, Dang TM et al. Antibody escape of SARS-CoV-2 variants of concern on receptor-binding domain: A computational approach. J Theor Biol. 2026. https://pubmed.ncbi.nlm.nih.gov/41360318/

[14] Ishwar D, Padavu S, Kumar M et al. In silico design of a multi-epitope vaccine targeting DENV-1 and DENV-3. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/41545417/

[15] Izhari MA, Gosady ARA, Alghamdi F et al. Rational design and in silico characterization of a multiepitope mRNA vaccine candidate against human metapneumovirus (hMPV) using reverse vaccinology and immunoinformatics approaches. Sci Rep. 2025. https://pubmed.ncbi.nlm.nih.gov/41444309/

[16] Bukhari K. Multi-epitope vaccine design against human metapneumovirus via reverse vaccinology and molecular modelling. Sci Rep. 2025. https://pubmed.ncbi.nlm.nih.gov/41274916/

[17] Tombari W, Khamessi O, Othman H et al. A novel mRNA-based multi-epitope vaccine for rabies virus computationally designed via reverse vaccinology and immunoinformatics. Sci Rep. 2025. https://pubmed.ncbi.nlm.nih.gov/40830404/

[18] Alshahrani M, Parikh V, Foley B et al. Dynamic mutational profiling of binding interactions and allosteric networks in conformational ensembles of the SARS-CoV-2 spike protein complexes with classes of antibodies targeting cryptic binding sites: confluence of binding and allostery determines molecular mechanisms and hotspots of immune escape. Phys Chem Chem Phys. 2025. https://pubmed.ncbi.nlm.nih.gov/40842437/

[19] Fath MK. The novel design of a multi-epitope vaccine candidate against the dengue virus using advanced immunoinformatics and structural analysis. J Bioinform Comput Biol. 2025. https://pubmed.ncbi.nlm.nih.gov/41083417/

[20] Naveed M, Asim M, Aziz T et al. Development of a broad-spectrum multiepitope vaccine against dabie bandavirus through immunoinformatic approaches. Int Immunopharmacol. 2025. https://pubmed.ncbi.nlm.nih.gov/40961753/

[21] Saadh MJ, Muhammad FA, Albadr RJ et al. Structure-based design of a multi-epitope vaccine candidate against marburg virus using immunoinformatics and dynamics simulations. J Mol Graph Model. 2025. https://pubmed.ncbi.nlm.nih.gov/40782386/

[22] Ait Lahcen N, Liman W, Zekri S et al. QSAR-Guided and Fragment-Based Drug Design of Monoterpenoid Inhibitors Targeting Ebola Virus Glycoprotein. Int J Mol Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41977174/

[23] Gul Z, Shahid SA, Abid OU et al. Discovery of thiadiazole-based small-molecule inhibitors of SARS-CoV-2 spike-ACE2 interaction through integrated computational prediction and experimental validation. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/41484143/

[24] Sattar A, Jahromi BS, Ghahi FSJ et al. Computational screening and molecular modeling of probiotic-derived peptides targeting the conserved HR1 domain of SARS-CoV-2 spike protein. Sci Rep. 2025. https://pubmed.ncbi.nlm.nih.gov/41461805/

[25] Ullah F, Xiao A, Ullah S et al. Synergizing Attribute-Guided Latent Space Exploration (AGLSE) with Classical Molecular Simulations to Design Potent Pep-Magnet Peptide Inhibitors to Abrogate SARS-CoV-2 Host Cell Entry. Viruses. 2025. https://pubmed.ncbi.nlm.nih.gov/40573419/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[26] Tayyeb JZ, da Silva MK, Al-Mutairi AA et al. Evaluation of Potential Inhibitors of Zika Virus Envelope Protein Through Molecular Docking and Molecular Dynamics Simulation. Virus Res. 2025. https://pubmed.ncbi.nlm.nih.gov/40945531/

[27] Sampaio de Sousa D, Moreira de Oliveira V, Silva Marinho E et al. Insights of potential action with acyclovir analogs for the control of white spot syndrome virus (WSSV): Molecular dynamics and ecotoxicological analysis approach. Microb Pathog. 2025. https://pubmed.ncbi.nlm.nih.gov/40774562/

[28] Yasaghi M, Dolatabadi SB, Yamchi A et al. Insights into the antiviral mechanisms of β-caryophyllene: inhibiting viral spread and its synergy with acyclovir. BMC Complement Med Ther. 2025. https://pubmed.ncbi.nlm.nih.gov/40634910/

[29] Khan A, Alzahrani AR, Rehman ZU et al. Structure-Guided Engineering of High-Affinity Antibodies Against Zika Virus Using Deep Learning and Molecular Dynamics. Chem Biodivers. 2026. https://pubmed.ncbi.nlm.nih.gov/41205205/

[30] Aktaş E, Öztürk S, Tarhan B. Integrative computational analysis of Marburg virus protein mutations: structural and functional implications of Glycoprotein variants and natural inhibitor screening. J Biomol Struct Dyn. 2026. https://pubmed.ncbi.nlm.nih.gov/41903124/

[31] Jiang D, Wang Y, Kang H et al. Immunoreactivity of pan MHC-I epitopes on Crimean-Congo hemorrhagic fever virus glycoprotein C-terminal. Front Immunol. 2026. https://pubmed.ncbi.nlm.nih.gov/41859109/

[32] Kumar P, Chen L, Chen RY et al. AI-Guided Binding Mechanisms and Molecular Dynamics for MERS-CoV. Int J Mol Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41752125/

[33] Mounadi N, Nour H, Abass KS et al. Exploring Drug Repurposing for Influenza A (H3N2) Virus: A Computational Approach to Identifying Commercialized Drugs Targeting Hemagglutinin, Neuraminidase, and Nucleoprotein. J Chem Inf Model. 2025. https://pubmed.ncbi.nlm.nih.gov/41108225/

[34] Habib A, Xu X, Xie J et al. Immunoinformatic Prediction of HIV-1 Glycoprotein gp120 and Nef Epitopes Conjugated to HBsAg-Binding Protein (SBP) to Induce the Humoral and Cellular Immune Response. Int J Mol Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/41097091/

[35] Reiné J, Tinnirello R, Cagigi A et al. A retrospective computational validation of a clinically evaluated recombinant envelope protein tetravalent dengue vaccine. Int J Biol Macromol. 2025. https://pubmed.ncbi.nlm.nih.gov/40975348/